MBX Biosciences (MBX) Treasury Shares (2023 - 2026)

MBX Biosciences has disclosed Treasury Shares across 4 years of filings, most recently posting $163562.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $163562.0, up 1908.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $163562.0 (up 1908.13% YoY), and the FY2025 annual result was $694.0, down 94.5% from the prior year.
• Treasury Shares came in at $163562.0 for Q1 2026 at MBX Biosciences, up from $694.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $163562.0 in Q1 2026 to a low of $694.0 in Q4 2025.
• The 4-year median for Treasury Shares is $8193.5 (2024), against an average of $36395.8.
• Across the five-year window, Treasury Shares tumbled 94.5% in 2025 and jumped 1908.13% in 2026, its largest moves.
• MBX Biosciences' Treasury Shares stood at $90324.0 in 2023, then sank by 86.04% to $12608.0 in 2024, then sank by 94.5% to $694.0 in 2025, then surged by 23468.01% to $163562.0 in 2026.
• The last three Treasury Shares figures came in at $163562.0 (Q1 2026), $694.0 (Q4 2025), and $2514.0 (Q3 2025), per Business Quant data.